<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24539">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787304</url>
  </required_header>
  <id_info>
    <org_study_id>SHP626-201</org_study_id>
    <secondary_id>2016-000203-82</secondary_id>
    <nct_id>NCT02787304</nct_id>
  </id_info>
  <brief_title>Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)</brief_title>
  <official_title>A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the investigational treatment volixibat
      (SHP626) is safe, tolerable and effective in adults with nonalcoholic steatohepatitis
      (NASH).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of Volixibat compared to placebo on liver histology as assessed by a reduction of fibrosis from baseline nonalcoholic fatty liver disease (NAFLD) activity score (NAS)</measure>
    <time_frame>Baseline to Week 48</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effect of Volixibat compared to placebo as measured by hepatic steatosis</measure>
    <time_frame>Baseline to Week 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of Volixibat compared to placebo as measured by serum liver-related biochemistry</measure>
    <time_frame>Baseline to Week 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of Volixibat compared to placebo as measured by metabolic indicators</measure>
    <time_frame>Baseline to Week 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of Volixibat compared to placebo as measured by serum lipids</measure>
    <time_frame>Baseline to Week 48</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">266</enrollment>
  <condition>Non-Alcoholic Steatohepatitis</condition>
  <arm_group>
    <arm_group_label>Experimental Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5mg SHP626 by mouth once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10mg SHP626 by mouth once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Arm 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20mg SHP626 by mouth once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo capsule by mouth once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SHP626</intervention_name>
    <description>5mg, 10mg, 20mg</description>
    <arm_group_label>Experimental Arm 3</arm_group_label>
    <arm_group_label>Experimental Arm 2</arm_group_label>
    <arm_group_label>Experimental Arm 1</arm_group_label>
    <other_name>Volixibat (SHP626)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo</description>
    <arm_group_label>Placebo Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male, or non-pregnant, non-lactating female who is sexually active and who agrees to
             comply with the contraceptive requirements of the protocol or females of
             non-childbearing potential.

          2. Presence of ≥ 5% steatosis on screening MRI from a centrally read radiologist
             performed either during the screening period or within 6 months prior to the first
             visit.

          3. Histologic confirmation of NASH without cirrhosis (fibrosis stage 1, 2, or 3) from a
             centrally read liver biopsy performed either during the screening period or within 6
             months prior to the first visit with a NAS of ≥ 4 with a score of at least 1 in each
             component (steatosis, lobular inflammation, and hepatocyte ballooning).

        Exclusion Criteria:

          1. Presence of or history of cirrhosis or evidence of decompensated liver disease or
             hepatocellular carcinoma

          2. History or presence of other concomitant liver disease as assessed by the
             investigator or determined by laboratory findings

          3. Current or recurrent disease that could affect the action, absorption, disposition,
             or laboratory assessment of the IP (including bile salt metabolism in the intestine)

          4. Weight change ≥5% after qualifying liver biopsy and/or MRI performed. If the subject
             had a liver biopsy and/or MRI within 6 months of screening, but experienced a weight
             change ≥5% since the date of liver biopsy and/or MRI, the liver biopsy and/or MRI
             must be repeated at screening.

          5. Inability to do an MRI (ie, claustrophobia, coronary stents, coronary implantable
             devices, girth, etc.).

          6. Current or relevant history of physical or psychiatric illness, any medical disorder
             that may require treatment or make the subject unlikely to complete the study.

          7. Uncontrolled diabetes defined as HbA1c of ≥ 9.0% within 60 days prior to enrollment.

          8. Current use of any medication (including over-the-counter, herbal, or homeopathic
             preparations) that could affect the action, absorption, or disposition of the IP, or
             clinical or laboratory assessment.

          9. Use of drugs, herbs or supplements historically associated with causing or worsening
             NAFLD/NASH for less than 6 months prior to qualifying liver biopsy, or initiated any
             time after qualifying liver biopsy performed, including the use of total parenteral
             nutrition (TPN).

         10. Serum AST &gt; 5 times upper limit of normal (ULN) at screening.

         11. Serum ALT &gt; 5 times ULN at screening.

         12. Elevated serum creatinine ≥ 2.0 mg/dL.

         13. International normalized ratio (INR) &gt;1.3.

         14. Total bilirubin (TB) ≥ 2.0 x ULN at screening (Except for documented Gilbert's
             syndrome with bilirubin levels 20 µmol/L to 90 µmol/L (1.2 to 5.3 mg/dL) and with a
             ratio of unconjugated/conjugated bilirubin that is commensurately higher).

         15. Platelet count &lt; 130 × 109L

         16. Medical history of impaired hemostasis or use of anticoagulant medication (use of
             antiplatelet medications, such as low-dose, ie 81mg aspirin (ASA) or clopidogrel
             (Plavix) will be allowed).

         17. Uncontrolled thyroid disease.

         18. Type 1 diabetes mellitus.

         19. Known or suspected intolerance or hypersensitivity to the IP, closely-related
             compounds, or any of the stated ingredients.

         20. Known history of alcohol or other substance abuse within the last year. Weekly
             alcohol intake greater than 21 grams/day for males and 14 grams/day for females on
             average or inability to reliably quantify alcohol consumption based on investigator's
             judgment.

         21. Inability to safely obtain a liver biopsy.

         22. The anticipated need for a surgical procedure during the study that could interfere
             with the treatment.

         23. Known positivity for human immunodeficiency virus (HIV) infection.

         24. Cancer within 5 years of screening, except for basal or squamous cell carcinoma of
             the skin or in situ cervical carcinoma that has been treated with no evidence of
             recurrence.

         25. History of noncompliance with medical regimens, unreliability, mental instability or
             incompetence that could compromise the validity of informed consent or lead to
             noncompliance with the study protocol.

         26. Any other conditions or abnormalities which, in the opinion of the investigator, may
             compromise the safety of the subject, or interfere with the subject participating.

         27. Subject has failed screening or was previously enrolled in this study or is currently
             enrolled in this study at any study site (unless the subject is transferring to
             another qualified study site with prior Sponsor approval).

         28. Females who are pregnant, planning to become pregnant, or are breastfeeding, or males
             who are planning to father a child during study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Physician</last_name>
    <role>Study Director</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Call Contact</last_name>
    <email>clinicaltransparency@shire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Southern California Research Center</name>
      <address>
        <city>Coronado</city>
        <state>California</state>
        <zip>92118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarek Hassanein</last_name>
      <phone>619-522-0330</phone>
      <email>thassanein@livercenters.com</email>
    </contact>
    <investigator>
      <last_name>Tarek Hassanein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fresno Clinical Research Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Sheikh</last_name>
      <phone>559-970-3441</phone>
      <email>liverdisease@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Muhammad Sheikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ceders-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mazen Noureddin, MD</last_name>
      <phone>310-423-7088</phone>
      <email>mazen.noureddin@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Mazen Noureddin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Liver Research Institute</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Mena, MD</last_name>
      <phone>626-440-7325</phone>
    </contact>
    <investigator>
      <last_name>Edward Mena, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inland Empire Liver Foundation</name>
      <address>
        <city>Rialto</city>
        <state>California</state>
        <zip>92377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeid Kayali</last_name>
      <phone>909-883-2999</phone>
      <email>zkayali@ieliverfoundation.com</email>
    </contact>
    <investigator>
      <last_name>Zeid Kayali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Denver Gastroenterology, PC</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo Kugelmas</last_name>
      <phone>303-406-4139</phone>
      <email>kugelmas@gutfeelings.com</email>
    </contact>
    <investigator>
      <last_name>Marcelo Kugelmas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington (GW) Medical Faculty Associates</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Latham</last_name>
      <phone>202-994-5057</phone>
      <email>platham@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Patricia Latham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schiff Center for Liver Diseases</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugene Schiff</last_name>
      <phone>305-243-4615</phone>
      <email>eschiff@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Schiff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Florida Center of Gastroenterology</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitchell Davis</last_name>
      <phone>561-798-2425</phone>
      <email>mdavis@digestivecareonline.com</email>
    </contact>
    <investigator>
      <last_name>Mitchell Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Internal Medicine Associates of Wellstar Atlanta Medical</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Pearlman</last_name>
      <phone>404-265-1044</phone>
      <email>BrianPearlman3@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Brian Pearlman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Vos</last_name>
      <phone>404-785-1281</phone>
      <email>mvos@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Miriam Vos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Specialists of Georgia</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aasim Sheikh, Dr</last_name>
      <phone>679-819-4217</phone>
      <email>asheikh@gigeorgia.com</email>
    </contact>
    <investigator>
      <last_name>Aasim Sheikh, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Queen's Medical Center - Liver Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naoky Tsai</last_name>
      <phone>808-691-7609</phone>
      <email>naoky@hawii.edu</email>
    </contact>
    <investigator>
      <last_name>Naoky Tsai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Sanchez</last_name>
      <phone>319-384-7283</phone>
      <email>Antonio-sanchez@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Antonio Sanchez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liver Research Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Smart</last_name>
      <phone>502-852-6991</phone>
      <email>Laura.Smart@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Laura Smart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University Health Sciences Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fredric Regenstein</last_name>
      <phone>504-988-1619</phone>
      <email>fregens@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>Fredric Regenstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana Research Center, LLC</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Dies</last_name>
      <phone>318-631-9121</phone>
      <email>dfdies@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>David Dies, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Thuluvath, MD</last_name>
      <phone>410-332-9356</phone>
    </contact>
    <investigator>
      <last_name>Paul Thuluvath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Disease Associates</name>
      <address>
        <city>Catonsville</city>
        <state>Maryland</state>
        <zip>21228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natarajan Ravendhran, MD</last_name>
      <phone>410-737-0053</phone>
      <email>n.ravendhran@ddamd.com</email>
    </contact>
    <investigator>
      <last_name>Natarajan Ravendhran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Lai</last_name>
      <phone>617-632-1094</phone>
      <email>mlai@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michelle Lai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyongyi Szabo</last_name>
      <phone>508-856-6113</phone>
      <email>Gyongyi.Szabo@umassmed.edu</email>
    </contact>
    <investigator>
      <last_name>Gyongyi Szabo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart Gordon, MD</last_name>
      <phone>313-916-9465</phone>
      <email>sgordon3@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Stuart Gordon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Borg, MD</last_name>
      <phone>601-984-4540</phone>
      <email>bborg@umc.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Borg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City Research Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley Freilich</last_name>
      <phone>816-759-5274</phone>
      <email>brad@kcgastro.com</email>
    </contact>
    <investigator>
      <last_name>Bradley Freilich, Freilich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arifa Toor</last_name>
      <phone>603-650-5261</phone>
      <email>Arifa.Toor@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Arifa Toor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health Inc.</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Bernstein</last_name>
      <phone>516-562-4664</phone>
      <email>dbernste@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>David Bernstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Concorde Medical Group PLLC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hillel Tobias</last_name>
      <phone>212-889-5544</phone>
      <email>docstobias@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hillel Tobias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Huang</last_name>
      <phone>585-275-4711</phone>
      <email>jonathan_huang@urmc.rochester.ed</email>
    </contact>
    <investigator>
      <last_name>Jonathan Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Liver Disease</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew deLemos</last_name>
      <phone>704-355-6649</phone>
      <email>Andrew.delemos@carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Andrew deLemos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DUMC-Gastroenterology</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manal Abdelmalek</last_name>
      <phone>919-684-3262</phone>
      <email>manal.abdelmalek@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Manal Abdelmalek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cumberland Research Associates, LLC</name>
      <address>
        <city>Fayetteville</city>
        <state>North Carolina</state>
        <zip>28304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Poulos</last_name>
      <phone>910-484-8163</phone>
      <email>Cumberland@cumberlandresearchassociates.com</email>
    </contact>
    <investigator>
      <last_name>John Poulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Center for Liver Disease</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28677</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Reindollar</last_name>
      <phone>704-978-0044</phone>
      <email>robert.reindollar@piedmonthealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Robert Reindollar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaideep Behari</last_name>
      <phone>412-647-4932</phone>
      <email>behajx@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Jaideep Behari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Don Rockey</last_name>
      <phone>843-792-2914</phone>
      <email>rockey@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Don Rockey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinsearch, LLC</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Krause</last_name>
      <phone>423-698-4584</phone>
      <email>rkrause@clinsearch-us.com</email>
    </contact>
    <investigator>
      <last_name>Richard Krause, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of TN Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>038104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjaya Satapathy</last_name>
      <phone>901-516-6014</phone>
      <email>ssatapat@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>Sanjaya Satapathy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quality Medical Research</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Herring Jr.</last_name>
    </contact>
    <investigator>
      <last_name>Robert Herring Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Center for Clinical Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imtiaz Alam, MD</last_name>
    </contact>
    <investigator>
      <last_name>Imtiaz Alam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Health Systems Clinical</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adil Habib</last_name>
      <phone>214-947-4450</phone>
      <email>AdilHabib@mhd.com</email>
    </contact>
    <investigator>
      <last_name>Adil Habib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine - Advanced Liver Therapies</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John M Vierling</last_name>
      <phone>713-798-7966</phone>
      <email>vierling@bcm.com</email>
    </contact>
    <investigator>
      <last_name>John M Vierling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DHAT Research Institute</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75082</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harry Sarles</last_name>
      <phone>972-487-1436</phone>
      <email>harry.sarles@dhat.com</email>
    </contact>
    <investigator>
      <last_name>Harry Sarles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UVM Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Lidofsky</last_name>
      <phone>802-847-2554</phone>
      <email>steven.lidofsky@uvm.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Lidofsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive and Liver Disease Specialists</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Smith</last_name>
      <phone>757-466-0165</phone>
      <email>jhsresearch@dlds.org</email>
    </contact>
    <investigator>
      <last_name>John Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bon Secours Liver Institute of Virginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitchell Shiffman</last_name>
      <phone>804-977-8920</phone>
      <email>Mitchell_shiffman@bshsi.org</email>
    </contact>
    <investigator>
      <last_name>Mitchell Shiffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arun Sanyal</last_name>
      <phone>804-828-4060</phone>
      <email>arun.sanyal@cvuheath.org</email>
    </contact>
    <investigator>
      <last_name>Arun Sanyal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blaire Burman</last_name>
      <phone>206-223-2319</phone>
      <email>blaire.burman@virginiamason.org</email>
    </contact>
    <investigator>
      <last_name>Blaire Burman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UW Digestive Health Center (DHC)</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adnan Said</last_name>
      <phone>608-263-4034</phone>
      <email>axs@medicine.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Adnan Said, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary Liver Unit</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Eksteen, MD</last_name>
      <phone>1-403-220-3719</phone>
      <email>B.eksteen@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Johannes Eksteen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LAIR Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1H2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Tam, MD</last_name>
      <phone>604-876-5122</phone>
      <email>etam@laircentre.com</email>
    </contact>
    <investigator>
      <last_name>Edward Tam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver ID Research and Care Centre Society</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 2C7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Conway</last_name>
      <phone>604-642-6429</phone>
      <email>brian.conway@vidc.ca</email>
    </contact>
    <investigator>
      <last_name>Brian Conway, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Heath Authority</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3HJ 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus McLeod</last_name>
      <phone>902-473-3246</phone>
      <email>magnus.mcleod@nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Magnus McLeod, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto Liver Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6H 3M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdy Elkhashab</last_name>
      <phone>416-652-2512</phone>
      <email>melkashabmd@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Magdy Elkhashab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CRCHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanne-Marie Giard</last_name>
      <phone>514-890-8000</phone>
      <email>Jeannemariegiard@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jeanne-Marie Giard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPR: Medical Sciences Campus</name>
      <address>
        <city>San Juan</city>
        <zip>00935</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose E Rivera</last_name>
      <phone>787-754-0101</phone>
      <email>jose.rivera120@upr.edu</email>
    </contact>
    <investigator>
      <last_name>Jose E Rivera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham</name>
      <address>
        <city>West Midlands</city>
        <state>Birmingham</state>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Newsome</last_name>
      <phone>44-1214-721311</phone>
      <email>P.N.Newsome@bham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Philip Newsome, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NHS Tayside</name>
      <address>
        <city>Taysdie</city>
        <state>Dundee City</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Dillon</last_name>
      <phone>44-1382-632334</phone>
      <email>j.f.dillon@dundee.ac.uk</email>
    </contact>
    <investigator>
      <last_name>John Dillon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>Hampstead</city>
        <state>London</state>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanouil</last_name>
      <phone>44-20-7794-0500</phone>
      <email>emmanouil.tsochatzis@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Emmanouil Tsochatzis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norfolk &amp; Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arun Shankar</last_name>
      <phone>01603 288234</phone>
      <email>arun.shankar@nnuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Arun Shankar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <state>Oxfordshire</state>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Cobbold</last_name>
      <phone>44-01865-228756</phone>
      <email>Jeremy.Cobbold@ouh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jeremy Cobbold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Alazawi, MD</last_name>
      <phone>44-020-3594-6773</phone>
      <email>w.alazawi@qmul.ac.uk</email>
    </contact>
    <investigator>
      <last_name>William Alazawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham Digestive Diseases Centre and Biomedical Research Unit</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guruprasad Aithal</last_name>
      <phone>44-0115-9249924 70441</phone>
      <email>guru.aithal@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Guruprasad Aithal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abertawe Bro Morgannwg University</name>
      <address>
        <city>Swansea</city>
        <zip>SA2 8QA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chin Ch'ng</last_name>
      <phone>44-792-285809</phone>
      <email>chinlye.chng@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chin Ch'ng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>York Clinical Research Facility</name>
      <address>
        <city>York</city>
        <zip>YO31 8HE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Millson, MD</last_name>
      <phone>44-01904-721893</phone>
      <email>Charles.Millson@york.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Charles Millson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Puerto Rico</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.theviastudy.com/</url>
    <description>For More Information on The VIA Study</description>
  </link>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 30, 2017</lastchanged_date>
  <firstreceived_date>May 11, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NAFLD activity score</keyword>
  <keyword>ASBTi</keyword>
  <keyword>MRI PDFF</keyword>
  <keyword>NAS</keyword>
  <keyword>NAFLD</keyword>
  <keyword>liver disease</keyword>
  <keyword>ASBT</keyword>
  <keyword>MRI proton density fat fraction</keyword>
  <keyword>nonalcoholic steatohepatitis</keyword>
  <keyword>apical sodium dependent bile acid transporter inhibitor</keyword>
  <keyword>fatty liver</keyword>
  <keyword>NASH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bile Acids and Salts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
